Showing results (621-630 of 649) with videos related to
Sort By:
Pageof 65
Endocrinology and Metabolism (Seoul, Korea)|January 2, 2026
Consensus on the Diagnosis of Cushing's Disease: A Collaborative Statement from the Korean Endocrine Society and Japan Endocrine SocietyJeongmin Lee, Hidenori Fukuoka, Seung Shin Park, et al.Plos One|August 4, 2017
CKAP2 (cytoskeleton-associated protein2) is a new prognostic marker in HER2-negative luminal type breast cancerSung Hoon Sim, Chang-Dae Bae, Youngmi Kwon, et al.Endocrine Journal|January 25, 2026
Consensus on the diagnosis of Cushing's disease: a collaborative statement from the Korean Endocrine Society and Japan Endocrine SocietyJeongmin Lee, Hidenori Fukuoka, Seung Shin Park, et al.Journal of Medicinal Chemistry|October 2, 2008
Design, synthesis, and biological evaluation of novel constrained meta-substituted phenyl propanoic acids as peroxisome proliferator-activated receptor alpha and gamma dual agonistsYoung-Ger Suh, Nam-Jung Kim, Bon-Woong Koo, et al.Experimental & Molecular Medicine|April 15, 2024
Loss of SREBP-1c ameliorates iron-induced liver fibrosis by decreasing lipocalin-2Eun-Ho Lee, Jae-Ho Lee, Do-Young Kim, et al.Bioorganic & Medicinal Chemistry Letters|May 17, 2011
Discovery of DA-1229: a potent, long acting dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetesHeung Jae Kim, Woo Young Kwak, Jong Pil Min, et al.BMJ Open|April 25, 2020
Korean frailty and aging cohort study (KFACS): cohort profileChang Won Won, Seoyoon Lee, Jinhee Kim, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 20, 2024
A randomized phase II study of secondary cytoreductive surgery in patients with relapsed ovarian cancer who have progressed on a PARP inhibitor as first-line maintenance therapy: the SOCCER-P study (KGOG 3067/JGOG 3036/APGOT-OV11)Hyun-Woong Cho, Hee-Seung Kim, Jeong-Yeol Park, et al.Cancers|November 3, 2020
Real-World Experience of Pembrolizumab Monotherapy in Patients with Recurrent or Persistent Cervical Cancer: A Korean Multi-Center Retrospective Study (KGOG1041)Min Chul Choi, Yong-Man Kim, Jeong-Won Lee, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
A randomized phase II study of secondary cytoreductive surgery in patients with relapsed ovarian cancer who have progressed on a PARP inhibitor as first-line maintenance therapy: the SOCCER-P study (KGOG 3067/JGOG 3036/APGOT-OV11)Hyun-Woong Cho, Hee-Seung Kim, Jeong-Yeol Park, et al.Pageof 65